MANUFACTURERS LIFE INSURANCE COMPANY, THE - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 108 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,482,591
+259.8%
99,436
+164.2%
0.00%
Q2 2023$412,049
+284.0%
37,630
+9.1%
0.00%
Q1 2022$107,311
-19.3%
34,505
-12.0%
0.00%
Q4 2021$133,000
+64.2%
39,219
+76.1%
0.00%
Q3 2021$81,000
-56.5%
22,272
-47.9%
0.00%
Q2 2021$186,000
-1.6%
42,743
+2.4%
0.00%
Q1 2021$189,000
-20.3%
41,734
+1.2%
0.00%
Q4 2020$237,000
-19.1%
41,254
+2.0%
0.00%
Q3 2020$293,000
+96.6%
40,426
-3.6%
0.00%
Q2 2020$149,000
+115.9%
41,925
-9.8%
0.00%
Q1 2020$69,000
-14.8%
46,461
+12.9%
0.00%
Q4 2019$81,000
-63.2%
41,169
-3.0%
0.00%
Q3 2019$220,000
-27.6%
42,4300.0%0.00%
Q2 2019$304,000
-39.2%
42,430
+12.5%
0.00%
-100.0%
Q1 2019$500,000
+73.0%
37,701
+2.7%
0.00%
Q4 2018$289,000
-31.0%
36,716
-3.1%
0.00%
Q3 2018$419,000
-26.6%
37,883
-11.0%
0.00%
-100.0%
Q2 2018$571,000
+57000.0%
42,572
+16465.0%
0.00%
Q2 2017$1,0000.0%2570.0%0.00%
Q1 2017$1,0002570.0%0.00%
Q4 2016$0
-100.0%
2570.0%0.00%
Q3 2016$1,0002570.0%0.00%
Q2 2016$02570.0%0.00%
Q1 2016$02570.0%0.00%
Q4 2015$0
-100.0%
2570.0%0.00%
Q3 2015$1,0000.0%2570.0%0.00%
Q2 2015$1,000
-50.0%
2570.0%0.00%
Q1 2015$2,000
-33.3%
2570.0%0.00%
Q4 2014$3,0002570.00%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,641,804$7,454,0006.54%
COMMODORE CAPITAL LP 2,983,513$13,545,0005.40%
Foresite Capital Management IV, LLC 1,787,094$8,113,0000.97%
Avoro Capital Advisors LLC 10,300,000$46,762,0000.81%
Boxer Capital, LLC 4,000,000$18,160,0000.62%
Sio Capital Management, LLC 562,339$2,553,0000.52%
ACUTA CAPITAL PARTNERS, LLC 315,341$1,432,0000.52%
CM Management, LLC 150,000$681,0000.51%
APIS CAPITAL ADVISORS, LLC 120,000$545,0000.50%
Versant Venture Management, LLC 543,753$2,469,0000.48%
View complete list of CYMABAY THERAPEUTICS INC shareholders